Evidence map›Paper›PMID 21440507›Full record

ReviewTrends in parasitology2011

Tissue destruction and invasion by Entamoeba histolytica.

Katherine S Ralston, William A Petri

Abstract readReview
In one paragraph

Review in Trends in parasitology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Antiamoebic drugs for treating amoebic colitis.The Cochrane database of systematic reviews · 2019
    Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Evolution and ecology of commensal gut protists: recent advances.Current opinion in genetics & development · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. International journal of molecular sciences · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Gasdermins in Innate Host Defense AgainstFrontiers in immunology · 2022
    Review
  19. Journal of dental research · 2021
    Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Katherine S RalstonDepartment of Medicine, University of Virginia Health Sciences Center, Charlottesville, VA, USA.
William A Petri

Funding

INFECTIOUS DISEASES TRAINING PROGRAMT32AI007046 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Alison K Criss, William A Petri · 1985 to 2026
$15.3M
STRUCTURE/FUNCTION OF E HISTOLYTICA ADHERENCE LECTINR01AI026649 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI PETRI, WILLIAM A · 1989 to 2016
$6.1M
Role of CREM in Amebic Colitis and Inflammatory Bowel DiseaseR37AI026649 · NIAID · UNIVERSITY OF VIRGINIA · PI William A Petri · 2018 to 2026
$5.0M
NIAID NIH HHS 5R01 AI026649NIAID NIH HHS R01 AI026649NIAID NIH HHS R37 AI026649NIAID NIH HHS T32 AI007046
6 · The paper itself

Abstract

Entamoeba histolytica is the causative agent of amebiasis, a disease that is a major source of morbidity and mortality in the developing world. The potent cytotoxic activity of the parasite appears to underlie disease pathogenesis, although the mechanism is unknown. Recently, progress has been made in determining that the parasite activates apoptosis in target cells and some putative effectors have been identified. Recent studies have also begun to unravel the host genetic determinants that influence infection outcome. Thus, we are beginning to get a clearer picture of how this parasite manages to infect, invade and ultimately inflict devastating tissue destruction.

Indexed as

Cytotoxicity, ImmunologicApoptosisCell MovementChemotaxisCysteine ProteasesDysentery, AmebicEntamoeba histolyticaEntamoebiasisHost-Parasite InteractionsHumansImmunity, InnateIon ChannelsLiver Abscess, AmebicPhosphorylationProtozoan ProteinsReceptors, Leptinamoebapore proteins, protozoanCysteine ProteasesIon ChannelsProtozoan ProteinsReceptors, Leptin

Identifiers

PMID21440507
PMCPMC3104091

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.